CELIAC DISEASE
Clinical trials for CELIAC DISEASE explained in plain language.
Never miss a new study
Get alerted when new CELIAC DISEASE trials appear
Sign up with your email to follow new studies for CELIAC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug aims to shield celiac patients from Gluten's harm
Disease control CompletedThis study tested whether an investigational drug called KAN-101 could protect the intestines of people with celiac disease from damage caused by accidentally eating gluten. Fifty-five adults who follow a strict gluten-free diet were given either KAN-101 or a placebo and then und…
Matched conditions: CELIAC DISEASE
Phase: PHASE2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Experimental drug aims to shield celiac patients from Gluten's harm
Disease control CompletedThis study tested whether an experimental drug called TAK-101 could help adults with celiac disease who follow a gluten-free diet. Researchers wanted to see if TAK-101 could reduce symptoms and immune system reactions when participants were exposed to gluten. About 102 people rec…
Matched conditions: CELIAC DISEASE
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New infusion tested to tame gluten reaction in celiac patients
Disease control CompletedThis study tested a new medicine called TPM502, given by infusion, to see if it could help adults with celiac disease become more tolerant to gluten. Researchers wanted to know if the treatment was safe and if it changed the body's immune response to gluten. Participants received…
Matched conditions: CELIAC DISEASE
Phase: PHASE2 • Sponsor: Topas Therapeutics GmbH • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC
-
New drug tested to soothe stubborn celiac symptoms
Symptom relief CompletedThis study tested an investigational drug called PRV-015 in adults with celiac disease who still experienced symptoms like pain, bloating, and diarrhea despite following a strict gluten-free diet. The goal was to see if the drug could safely reduce these persistent symptoms. Part…
Matched conditions: CELIAC DISEASE
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Symptom relief
Last updated Apr 04, 2026 03:35 UTC